August 10, 2026 05:16 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute | 'They don't need Mohan Bhagwat's certificate': Priyanka Gandhi Vadra's sharp reply to RSS chief's Gen Z remark | 'Students, Gen Z, ask me anything': Rahul Gandhi launches Instagram Q&A, responds to Jharkhand protest | PM Modi goes Gen Z, urges Indians to share 'Get Ready With Me' videos on National Handloom Day | Former Tehelka editor Tarun Tejpal sentenced to 10-year jail term in 2013 rape case as Bombay HC overturns acquittal
COVID-19
Image Credit: UNI

COVID-19: Kerala to conduct Seroprevalence study to estimate population level immunity

| @indiablooms | Aug 28, 2021, at 04:37 pm

Thiruvananthapuram/UNI: The Kerala government has accorded sanction to conduct Seroprevalence study to estimate the population level immunity (level of herd immunity induced by both natural and the COVID-19 vaccines) in the state.

The study aims to get an insight into the dynamics of the COVID-19 pandemic and suggest strategies for prevention and control of the disease, according to the order issued by Principal Secretary (Health) Rajan Namdev Khobragade.

As Kerala faced the second wave of COVID-19 during the months of May and June 2021, the population behaviour, mobility and other factors are changing with the various stages of easing of the restrictions.

The primary objectives of the study are to estimate the seroprevalence of SARS CoV-2 IgG antibodies among ≥18 year old population, antenatal women attending antenatal care clinics, children aged 5 to 17 years, tribal population aged ≥18 yrs in rural parts of districts, people ≥18yrs in coastal areas and people ≥18yrs in slums areas in corporations of Kerala.

The secondary objectives are to study the determinants of seropositivity among the various study populations, among the categories of vaccination status in the study populations and estimate the case to infection ratio and infection fatality ratio in the general population.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.